A carregar...
Case Report: Re-Treatment With Lu-DOTATATE in Neuroendocrine Tumors
Peptide receptor radionuclide therapy (PRRT) is an established treatment in advanced neuroendocrine tumors (NETs), which overexpressed somatostatin receptors. However, after progression there are a limited number of available treatments. We want to share a case report about a patient with a NET re-t...
Na minha lista:
| Publicado no: | Front Endocrinol (Lausanne) |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8082310/ https://ncbi.nlm.nih.gov/pubmed/33935979 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2021.676973 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|